0

A-68930 hydrochloride

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP130465393
CAS130465-39-3
Structure
MDL NumberMFCD05863727
Molecular Weight307.77
InChI KeyPQPGUUQPTSMLKU-YYLIZZNMSA-N
Description≥98% (HPLC), powder
SolubilityH2O: soluble ~9 mg/mL
Assay≥98% (HPLC)
Coloroff-white to tan
Formpowder
Size10MG, 50MG
Storage Conditions−20°C
1

[D(1)-dopamine Receptor Is Involved in the Modulation of the Respiratory Rhythmical Discharge Activity in the Medulla Oblongata Slice Preparation of Neonatal Rats in Vitro]

Yong-Gang Jiao, Zhong-Hai Wu

Sheng Li Xue Bao. 2008 Dec 25;60(6):704-8.

PMID: 19082424

1

Cardiovascular and Renal Hemodynamic Effects of A-68930 in the Conscious Dog: A Comparison With Fenoldopam

M I Christie, G W Smith

J Pharmacol Exp Ther. 1994 Feb;268(2):565-70.

PMID: 7906731

1

Comparison of the D1-dopamine Agonists SKF-38393 and A-68930 in Neonatal 6-hydroxydopamine-lesioned Rats: Behavioral Effects and Induction of C-Fos-Like Immunoreactivity

K B Johnson, H E Criswell, K F Jensen, P E Simson, R A Mueller, G R Breese

J Pharmacol Exp Ther. 1992 Aug;262(2):855-65.

PMID: 1354257

1

D1 Receptor Antagonist-Induced Long-Term Depression in the Medial Prefrontal Cortex of Rat, in Vivo: An Animal Model of Psychiatric Hypofrontality

Rd Coppa-Hopman, J Galle, D Pimkine

J Psychopharmacol. 2009 Aug;23(6):672-85.

PMID: 18635697

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode